India seeks to mend Bangladesh ties with coronavirus vaccine diplomacy

The new law fast-tracks Indian citizenship for non-Muslims from three neighboring nations including Bangladesh

Coronavirus, bangladesh
An employee of the Mugda Medical College and Hospital in Dhaka. Photo: AFP/Getty Images
Archana Chaudhary & Arun Devnath | Bloomberg
2 min read Last Updated : Dec 17 2020 | 1:20 PM IST
India is expected to reassure Bangladesh it will prioritize the supply of Covid-19 vaccines to its South Asian neighbor, part of its vaccine outreach to counter China’s rising influence in the region.

India’s Prime Minister Narendra Modi and Bangladesh’s Sheikh Hasina are scheduled to meet Thursday in a virtual summit -- the first high-level meeting of the leaders from the two countries since relations nosedived when India passed its controversial religion-based citizenship law late last year.

The new law fast-tracks Indian citizenship for non-Muslims from three neighboring nations including Bangladesh. Foreign minister AK Abdul Momen and home minister Asaduzzaman Khan had both called off visits last December as nationwide protests against the law erupted in India.

New Delhi has since made overtures to smooth relations with Dhaka, with whom it has a long history of cooperative ties.

Indian foreign secretary Harsh Vardhan Shringla visited Bangladesh twice this year. The second visit in August came amid rising border tensions with China, which has committed $40 billion in investments in Bangladesh.

Discussions are expected to include trade, regional security and the restoration of a rail link between the two nations that had stopped functioning in 1965. Annual trade between India and Bangladesh stood at $10.25 billion in the fiscal year ended March 2019, Indian government data shows.

Dhaka is also expected to raise the issue of management of trans-boundary rivers including the long-pending water sharing agreement for river Teesta. India’s foreign minister Subrahmanyam Jaishankar and his counterpart Momen had in September noted their commitment to finalizing an interim deal in a dispute has lingered since the 1980s without any resolution.

The “long-drawn failure to sign the Teesta river water agreement” and the new citizenship law have together “unsettled public opinion in Bangladesh” against New Delhi despite decades of close ties, said Delwar Hossain, a professor of international relations at Dhaka University. “Now Covid-19 has brought the two nations together once again.”

Bangladesh’s Beximco Pharmaceuticals Ltd. signed an agreement with Serum Institute of India Pvt. in November for 30 million vaccine doses, shortly after India’s Jaishankar committed supplies to Dhaka during his meeting with Momen.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :India-BangladeshCoronavirus VaccineNarendra ModiHarsh Vardhan ShringlaS JaishankarSerum Institute of India

Next Story